vs
德康医疗（DXCM）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Reddit, Inc.的1.7倍（$1.3B vs $725.6M），Reddit, Inc.净利率更高（34.7% vs 21.2%，领先13.5%），Reddit, Inc.同比增速更快（69.7% vs 21.6%），过去两年Reddit, Inc.的营收复合增速更高（72.8% vs 12.0%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
DXCM vs RDDT — 直观对比
营收规模更大
DXCM
是对方的1.7倍
$725.6M
营收增速更快
RDDT
高出48.1%
21.6%
净利率更高
RDDT
高出13.5%
21.2%
两年增速更快
RDDT
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $725.6M |
| 净利润 | $267.3M | $251.6M |
| 毛利率 | 62.9% | 91.9% |
| 营业利润率 | 25.6% | 31.9% |
| 净利率 | 21.2% | 34.7% |
| 营收同比 | 21.6% | 69.7% |
| 净利润同比 | 153.6% | 254.2% |
| 每股收益（稀释后） | $0.67 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMRDDT
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $725.6M | ||
| Q3 25 | $1.2B | $584.9M | ||
| Q2 25 | $1.2B | $499.6M | ||
| Q1 25 | $1.0B | $392.4M | ||
| Q4 24 | $1.1B | $427.7M | ||
| Q3 24 | $994.2M | $348.4M | ||
| Q2 24 | $1.0B | $281.2M |
净利润DXCMRDDT
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $251.6M | ||
| Q3 25 | $283.8M | $162.7M | ||
| Q2 25 | $179.8M | $89.3M | ||
| Q1 25 | $105.4M | $26.2M | ||
| Q4 24 | $151.7M | $71.0M | ||
| Q3 24 | $134.6M | $29.9M | ||
| Q2 24 | $143.5M | $-10.1M |
毛利率DXCMRDDT
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 91.9% | ||
| Q3 25 | 60.5% | 91.0% | ||
| Q2 25 | 59.5% | 90.8% | ||
| Q1 25 | 56.9% | 90.5% | ||
| Q4 24 | 58.9% | 92.6% | ||
| Q3 24 | 59.7% | 90.1% | ||
| Q2 24 | 62.4% | 89.5% |
营业利润率DXCMRDDT
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 31.9% | ||
| Q3 25 | 20.1% | 23.7% | ||
| Q2 25 | 18.4% | 13.6% | ||
| Q1 25 | 12.9% | 1.0% | ||
| Q4 24 | 17.0% | 12.4% | ||
| Q3 24 | 15.3% | 2.0% | ||
| Q2 24 | 15.7% | -11.0% |
净利率DXCMRDDT
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 34.7% | ||
| Q3 25 | 23.5% | 27.8% | ||
| Q2 25 | 15.5% | 17.9% | ||
| Q1 25 | 10.2% | 6.7% | ||
| Q4 24 | 13.6% | 16.6% | ||
| Q3 24 | 13.5% | 8.6% | ||
| Q2 24 | 14.3% | -3.6% |
每股收益（稀释后）DXCMRDDT
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.24 | ||
| Q3 25 | $0.70 | $0.80 | ||
| Q2 25 | $0.45 | $0.45 | ||
| Q1 25 | $0.27 | $0.13 | ||
| Q4 24 | $0.37 | $4.76 | ||
| Q3 24 | $0.34 | $0.16 | ||
| Q2 24 | $0.35 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $953.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $2.9B |
| 总资产 | $6.3B | $3.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMRDDT
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $953.6M | ||
| Q3 25 | $1.8B | $911.7M | ||
| Q2 25 | $1.2B | $734.1M | ||
| Q1 25 | $904.9M | $635.7M | ||
| Q4 24 | $606.1M | $562.1M | ||
| Q3 24 | $621.2M | $515.9M | ||
| Q2 24 | $939.2M | $468.0M |
股东权益DXCMRDDT
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.7B | $2.6B | ||
| Q2 25 | $2.6B | $2.4B | ||
| Q1 25 | $2.3B | $2.2B | ||
| Q4 24 | $2.1B | $2.1B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.4B | $1.9B |
总资产DXCMRDDT
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.2B | ||
| Q3 25 | $7.5B | $2.9B | ||
| Q2 25 | $7.3B | $2.6B | ||
| Q1 25 | $6.8B | $2.4B | ||
| Q4 24 | $6.5B | $2.3B | ||
| Q3 24 | $6.4B | $2.2B | ||
| Q2 24 | $6.8B | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $266.8M |
| 自由现金流经营现金流 - 资本支出 | — | $263.6M |
| 自由现金流率自由现金流/营收 | — | 36.3% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | 1.06× |
| 过去12个月自由现金流最近4个季度 | — | $684.2M |
8季度趋势，按日历期对齐
经营现金流DXCMRDDT
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $266.8M | ||
| Q3 25 | $659.9M | $185.2M | ||
| Q2 25 | $303.0M | $111.3M | ||
| Q1 25 | $183.8M | $127.6M | ||
| Q4 24 | $301.4M | $90.0M | ||
| Q3 24 | $199.5M | $71.6M | ||
| Q2 24 | $279.4M | $28.4M |
自由现金流DXCMRDDT
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $263.6M | ||
| Q3 25 | $579.4M | $183.1M | ||
| Q2 25 | $208.9M | $110.8M | ||
| Q1 25 | $96.8M | $126.6M | ||
| Q4 24 | $176.8M | $89.2M | ||
| Q3 24 | $88.3M | $70.3M | ||
| Q2 24 | $213.3M | $27.2M |
自由现金流率DXCMRDDT
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 36.3% | ||
| Q3 25 | 47.9% | 31.3% | ||
| Q2 25 | 18.1% | 22.2% | ||
| Q1 25 | 9.3% | 32.3% | ||
| Q4 24 | 15.9% | 20.8% | ||
| Q3 24 | 8.9% | 20.2% | ||
| Q2 24 | 21.2% | 9.7% |
资本支出强度DXCMRDDT
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.4% | ||
| Q3 25 | 6.7% | 0.4% | ||
| Q2 25 | 8.1% | 0.1% | ||
| Q1 25 | 8.4% | 0.2% | ||
| Q4 24 | 11.2% | 0.2% | ||
| Q3 24 | 11.2% | 0.4% | ||
| Q2 24 | 6.6% | 0.4% |
现金转化率DXCMRDDT
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.06× | ||
| Q3 25 | 2.33× | 1.14× | ||
| Q2 25 | 1.69× | 1.25× | ||
| Q1 25 | 1.74× | 4.88× | ||
| Q4 24 | 1.99× | 1.27× | ||
| Q3 24 | 1.48× | 2.40× | ||
| Q2 24 | 1.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
RDDT
| Advertising | $689.7M | 95% |
| Other Revenue | $35.9M | 5% |
